Brief: Spruce Biosciences Reports First Quarter 2023 Financial Results And Provides Corporate Updates
15/05/2023 13:17
Spruce Biosciences Inc SPRB.O :
* SPRUCE BIOSCIENCES REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATES
* SPRUCE BIOSCIENCES INC - TOPLINE RESULTS IN P.O.W.E.R.
STUDY
FOR POLYCYSTIC OVARY SYNDROME ANTICIPATED IN Q3 2023
* SPRUCE BIOSCIENCES INC - CASH, CASH EQUIVALENTS AND
INVESTMENTS
AS OF MARCH 31, 2023 WERE $118.6 MILLION
* SPRUCE BIOSCIENCES INC - CASH BALANCE AND $15.0 MILLION
PAYMENT
UNDER AGREEMENT WITH KAKEN ARE EXPECTED TO FUND OPERATING & CAP
EX INTO H1 2025
* SPRUCE BIOSCIENCES INC- QTRLY LOSS PER SHARE $0.40
Source text for Eikon: ID:nBw2nwSqsa
Further company coverage: SPRB.O
Recent news on Spruce Biosciences
See all newsSpruce Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Spruce Biosciences Q2 net loss widens on higher expenses
Spruce Biosciences, Inc. expected to post a loss of $5.80 a share - Earnings Preview
Brief: Spruce Biosciences Appoints Adrian Quartel, M.D., Ffpm, As Chief Medical Officer
Brief: Spruce Biosciences Announces Data Presentation At The 18Th International MPS Symposium